
Weight Loss Drugs Show Promise for Treating Addiction Across Multiple Substances
VA study of 600,000 patients finds GLP-1 medications like Ozempic reduce substance use disorder risk by 15-20%, suggesting a common biological pathway underlying all addictions.







